Atrial Fibrillation Drugs Market Size to Worth USD 62.64 Billion by 2033 | Straits Research
The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...
Mena FN7d
Atrial Fibrillation Drugs Market Size To Worth USD 62.64 Billion By 2033 | Straits Research
(MENAFN- GlobeNewsWire - Nasdaq) The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD 27 billion in 2025 to USD 62.64 billion ...
Anti-clotting drug significantly reduces bleeding events in patients with atrial fibrillation, clinical trial shows
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...
Science Daily13d
Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Mena FN8d
Global Atrial Fibrillation Drugs Market Size, Supply, Forecast To 2033
Proactively managing atrial fibrillation is crucial for patients and healthcare providers, often necessitating the use of drugs due to the condition's propensity for severe consequences ...
FierceBiotech5h
Boston Scientific clocks over $1B in Farapulse revenue for the afib therapy’s first year
Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...
240-year-old drug could save UK NHS £100 million a year treating common heart rhythm disorder
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...
Healthline6d
Regular Flossing Linked to Better Heart Health, Reduced Stroke, AFib Risk
Poor oral health could be a potential risk factor for cardiovascular disease. New research shows that good oral health habits ...